| Osteopontin as a therapeutic target for cancer M Bandopadhyay, A Bulbule, R Butti, G Chakraborty, P Ghorpade, ... Expert opinion on therapeutic targets 18 (8), 883-895, 2014 | 145 | 2014 |
| RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer AS Yadav, NNV Radharani, M Gorain, A Bulbule, D Shetti, G Roy, T Baby, ... Nanoscale 12 (19), 10664-10684, 2020 | 77 | 2020 |
| Notch1-MAPK signaling axis regulates CD133+ cancer stem cell-mediated melanoma growth and angiogenesis D Kumar, S Kumar, M Gorain, D Tomar, HS Patil, NNV Radharani, ... Journal of Investigative Dermatology 136 (12), 2462-2474, 2016 | 75 | 2016 |
| Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway NNV Radharani, AS Yadav, R Nimma, TVS Kumar, A Bulbule, ... Cancer cell international 22 (1), 122, 2022 | 63 | 2022 |
| The biology and therapeutic implications of tumor dormancy and reactivation AS Yadav, PR Pandey, R Butti, NNV Radharani, S Roy, SR Bhalara, ... Frontiers in oncology 8, 72, 2018 | 57 | 2018 |
| Ultrahigh penetration and retention of graphene quantum dot mesoporous silica nanohybrids for image guided tumor regression R Prasad, NK Jain, AS Yadav, M Jadhav, NNV Radharani, M Gorain, ... ACS Applied Bio Materials 4 (2), 1693-1703, 2021 | 16 | 2021 |
| Role of osteopontin in tumor microenvironment: a new paradigm in cancer therapy R Butti, P Ghosh, KVS Totakura, RNN Venkata, R Nimma, GC Kundu Multi-targeted approach to treatment of cancer, 113-125, 2015 | 12 | 2015 |
| pH-responsive nanomedicine for breast cancer targeting AS Yadav, IG Kundu, NNV Radharani, B Mishra, GC Kundu Targeted Nanomedicine for Breast Cancer Therapy, 335-349, 2022 | 1 | 2022 |
| SARS-CoV-2: Origin, Pathogenesis and Therapeutic Interventions I Kundu, NNV Radharani, AS Yadav, S Patnaik, GC Kundu Coronaviruses 2 (7), 9-21, 2021 | 1 | 2021 |
| Oxidative stress: a key regulator of Breast cancer progression and drug resistance NNV Radharani, IG Kundu, AS Yadav, GC Kundu Handbook of Oxidative Stress in Cancer: Mechanistic Aspects, 1-15, 2020 | 1 | 2020 |
| Osteopontin, a Key Multifaceted Regulator in Tumor Progression and Immunomodulation VK Panda, B Mishra, AN Nath, R Butti, AS Yadav, D Malhotra, S Khanra, ... Preprints, 2024 | | 2024 |
Amit Singh YadavAssistant Researcher, Chemical Biology and Therapeutics, Lund University, SwedenAdresse e-mail validée de med.lu.se
